222. 一次性ネフローゼ症候群 [臨床試験数:234,薬物数:241(DrugBank:78),標的遺伝子数:59,標的パスウェイ数:185

Searched query = "Primary nephrotic syndrome", "Minimal change nephrotic syndrome", "MCNS", "Membranous nephropathy", "Focal segmental glomerulosclerosis", "FSGS", "Membranoproliferative glomerulonephritis", "MPGN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR-INR-170122122017-07-282017-08-01Use of sirolimus in patients with primary idiopathic membranous nephropathy: a prospective randomized control trialUse of sirolimus in patients with primary idiopathic membranous nephropathy: a prospective randomized control trial idiopathic membranous nephropathy1:Cyclosporine;2:cyclosporine combined with sirolimus;Renal Division, Peking University First HospitalNULLRecruiting1870Both1:35;2:35;China
2NCT00050713December 17, 200217/12/2002Sirolimus Therapy for Idiopathic and Lupus Membranous NephropathySirolimus Therapy in Idiopathic and Lupus Membranous NephropathyMembranous Glomerulonephritis;Lupus Membranous NepropathyDrug: SirolimusNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NULLCompleted13 YearsN/AAll12Phase 2United States
3NCT00040508June 200226/6/2002Sirolimus for Focal Segmental GlomerulosclerosisSirolimus for Focal Segmental GlomerulosclerosisFocal GlomerulosclerosisDrug: SirolimusNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NULLCompletedN/AN/ABoth30Phase 2United States